# An Epidemiological Study to Assess Iron Overload Using MRI in Patients With Transfusional Siderosis (TIMES Study)

> **NCT01736540** · PHASE4 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 243 (actual)

## Conditions studied

- Thalassemia, Non-transfusional-dependent Thalassemia (NTDT), Myeloplastic Dysplasia (MDS), Other Anemia

## Interventions

- **DEVICE:** MRI scan

## Key facts

- **NCT ID:** NCT01736540
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 243 (ACTUAL)
- **Last updated:** 2017-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01736540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01736540, "An Epidemiological Study to Assess Iron Overload Using MRI in Patients With Transfusional Siderosis (TIMES Study)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01736540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*